{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:12:51Z","timestamp":1793020371600,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cellimm.2023.104692","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T02:00:03Z","timestamp":1677117603000},"page":"104692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Alpha-galactosylceramide as adjuvant induces protective cell-mediated immunity against Leishmania mexicana infection in vaccinated BALB\/c mice"],"prefix":"10.1016","volume":"386","author":[{"given":"Mariana","family":"Diupotex","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Zamora-Chimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocely Buenaventura","family":"Cervantes-Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Salaiza-Suazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2023.104692_b0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2023.104692_b0010","doi-asserted-by":"crossref","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2023.104692_b0015","unstructured":"WHO, Leishmaniasis, The Global Health Observatory, (2021), https:\/\/apps.who.int\/neglected_diseases\/ntddata\/leishmaniasis\/leishmaniasis.html, (accessed February 21, 2022)."},{"key":"10.1016\/j.cellimm.2023.104692_b0020","doi-asserted-by":"crossref","unstructured":"J. Alvar, I.D. Velez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, M. den Boer, W.H.O.L.C. Team, Leishmaniasis worldwide and global estimates of its incidence, PloS one, 7 (2012) e35671, https:\/\/doi.org\/10.1371\/journal.pone.0035671.","DOI":"10.1371\/journal.pone.0035671"},{"key":"10.1016\/j.cellimm.2023.104692_b0025","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.4314\/ahs.v19i1.4","article-title":"Review of leishmaniasis in the middle east and north Africa","volume":"19","author":"Tabbabi","year":"2019","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.cellimm.2023.104692_b0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2023.104692_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2023.104692_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.685296","article-title":"Mechanisms of immunopathogenesis in cutaneous leishmaniasis and Post Kala-azar Dermal Leishmaniasis (PKDL)","volume":"11","author":"Volpedo","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cellimm.2023.104692_b0045","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/14760584.2021.1969231","article-title":"From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection","volume":"20","author":"Volpedo","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.cellimm.2023.104692_b0050","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2023.104692_b0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2023.104692_b0060","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.vaccine.2009.12.055","article-title":"Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infection","volume":"28","author":"Sakai","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2023.104692_b0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/S0074-02762011000200011","article-title":"An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cellimm.2023.104692_b0070","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0075","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3389\/fimmu.2018.02420","article-title":"Heterologous immunization with defined RNA and subunit vaccines enhances T cell responses that protect against Leishmania donovani","volume":"9","author":"Duthie","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0085","first-page":"247","article-title":"Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review, Pathog Glob","volume":"110","author":"Maspi","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.cellimm.2023.104692_b0090","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellimm.2023.104692_b0095","first-page":"1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","author":"Apostolico Jde","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cellimm.2023.104692_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100103","article-title":"Overview of vaccine adjuvants","volume":"11","author":"Wu","year":"2021","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.cellimm.2023.104692_b0105","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/S0040-4020(01)86991-X","article-title":"Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus","volume":"50","author":"Natori","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.cellimm.2023.104692_b0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3389\/fimmu.2019.01126","article-title":"alpha-GalCer and iNKT cell-based cancer immunotherapy: realizing the therapeutic potentials","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00251-016-0925-y","article-title":"Glycolipid activators of invariant NKT cells as vaccine adjuvants","volume":"68","author":"Kharkwal","year":"2016","journal-title":"Immunogenetics"},{"key":"10.1016\/j.cellimm.2023.104692_b0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.20011889","article-title":"Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines","volume":"195","author":"Gonzalez-Aseguinolaza","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104692_b0125","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.4049\/jimmunol.1403017","article-title":"Colocalization of a CD1d-Binding glycolipid with a radiation-attenuated sporozoite vaccine in lymph node-resident dendritic cells for a robust adjuvant effect","volume":"195","author":"Li","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0130","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.0900858","article-title":"Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin","volume":"183","author":"Venkataswamy","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0135","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2008.02.002","article-title":"Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide","volume":"26","author":"Huang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2023.104692_b0140","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1017\/S0031182016000949","article-title":"Leishmania mexicana: promastigotes and amastigotes secrete protein phosphatases and this correlates with the production of inflammatory cytokines in macrophages","volume":"143","author":"Escalona-Monta\u00f1o","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.cellimm.2023.104692_b0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cellimm.2023.104692_b0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1179\/136485908X252331","article-title":"Efficacy of RPMI 1640 and M 199 media in the isolation of Leishmania from cutaneous lesions","volume":"102","author":"Ihalamulla","year":"2008","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.cellimm.2023.104692_b0160","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Goto","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2023.104692_b0165","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.vaccine.2009.02.079","article-title":"Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection","volume":"27","author":"Goto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2023.104692_b0170","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.imbio.2016.11.014","article-title":"NKT cells in leishmaniasis","volume":"222","author":"Zamora-Chimal","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2023.104692_b0180","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/eji.200737660","article-title":"Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania","volume":"38","author":"Dondji","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0185","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2023.104692_b0190","first-page":"2645","article-title":"Interferon-gamma induced cell death: regulation and contributions of nitric oxide, cJun N-terminal kinase, reactive oxygen species and peroxynitrite","volume":"2014","author":"Rakshit","year":"1843","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellimm.2023.104692_b0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"Lima-Junior","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2023.104692_b0200","doi-asserted-by":"crossref","first-page":"41863","DOI":"10.18632\/oncotarget.6172","article-title":"Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model","volume":"6","author":"Ito","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2023.104692_b0205","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jid.2017.11.029","article-title":"IL-1beta production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis","volume":"138","author":"Santos","year":"2018","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2023.104692_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/febs.13546","article-title":"IL-1alpha and inflammasome-independent IL-1beta promote neutrophil infiltration following alum vaccination","volume":"283","author":"Oleszycka","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.cellimm.2023.104692_b0215","doi-asserted-by":"crossref","first-page":"e1004929","DOI":"10.1371\/journal.ppat.1004929","article-title":"Rapid sequestration of Leishmania mexicana by neutrophils contributes to the development of chronic lesion","volume":"11","author":"Hurrell","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2023.104692_b0220","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4049\/immunohorizons.2000076","article-title":"Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection","volume":"4","author":"Poudel","year":"2020","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.cellimm.2023.104692_b0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-022-00449-1","article-title":"Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis","volume":"7","author":"Volpedo","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.cellimm.2023.104692_b0230","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00705-017-3230-7","article-title":"Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus","volume":"162","author":"Fotouhi","year":"2017","journal-title":"Arch. Virol"},{"key":"10.1016\/j.cellimm.2023.104692_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines5040047","article-title":"Prophylactic sublingual immunization with Mycobacterium tuberculosis subunit vaccine incorporating the natural killer T cell agonist alpha-Galactosylceramide enhances protective immunity to limit pulmonary and extra-pulmonary bacterial burden in mice","volume":"5","author":"Khan","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.cellimm.2023.104692_b0240","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3389\/fimmu.2018.01519","article-title":"CD1d-invariant natural killer T cell-based cancer immunotherapy: alpha-galactosylceramide and beyond","volume":"9","author":"King","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0245","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1006662107","article-title":"Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2023.104692_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0255","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3389\/fimmu.2019.01912","article-title":"Neutrophil maturity in cancer","volume":"10","author":"Mackey","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0260","doi-asserted-by":"crossref","first-page":"e1003805","DOI":"10.1371\/journal.ppat.1003805","article-title":"iNKT cell production of GM-CSF controls Mycobacterium tuberculosis","volume":"10","author":"Rothchild","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2023.104692_b0265","first-page":"943","article-title":"In vitro effects of GM-CSF on mature peripheral blood neutrophils","volume":"1","author":"Fossati","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellimm.2023.104692_b0270","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3389\/fimmu.2018.01922","article-title":"GM-CSF quantity has a selective effect on granulocytic vs. monocytic myeloid development and function","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0275","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.171.8.4187","article-title":"IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha","volume":"171","author":"Giroux","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104692_b0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alph5a-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104692_b0285","series-title":"Immunopotentiators in Modern Vaccines","first-page":"211","article-title":"Natural vaccine adjuvants and immunopotentiators derived from plants, fungi, marine organisms, and insects","author":"Woods","year":"2017"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:10:17Z","timestamp":1757805017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492300031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":57,"alternative-id":["S000887492300031X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104692","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-galactosylceramide as adjuvant induces protective cell-mediated immunity against Leishmania mexicana infection in vaccinated BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104692"}}